DAVID A. SMITH - Corporate Board Profile

TIMBERLAND BANCORP INC

Filing Date	Source Excerpt
2001-12-21	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington.
2002-12-20	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington.
2003-12-24	The Board of Directors, acting as the Nominating Committee, has nominated for election as directors Michael R. Sand, David A. Smith and Harold L. Warren, each to serve for a three-year term, or until their respective successors have been elected and qualified. Each of the nominees for election as director are current members of the Board of Directors of the Company.
2003-12-24	The Audit Committee, consisting of Directors Backstrom, Warren, Robbel and Smith, receives and reviews all reports prepared by the Company's external and internal auditor. Each member of the Audit Committee is "independent" as defined in the Nasdaq Stock Market listing standards. The Audit Committee met seven times during the fiscal year ended September 30, 2003.
2004-12-21	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington. He serves on the Audit Committee.
2005-12-21	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington.
2006-12-15	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington. He serves on the Audit Committee.
2007-12-18	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington. The Audit Committee consists of Directors Warren, Robbel and Smith. The Nominating Committee currently consists of Directors Clinton, Smith, Robbel, Warren and Hamre. The following table shows the compensation paid to our non-employee directors for the fiscal year ended September 30, 2007. David A. Smith compensation total $37,385.
2008-12-19	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington. The Audit Committee currently consists of Directors Robbel, Smith and Mason. Director Warren was a member of the Audit Committee until his retirement on October 31, 2008. The Committee meets at least quarterly and on an as needed basis to evaluate the effectiveness of our internal controls for safeguarding assets and ensuring the integrity of the financial reporting. The Committee also appoints the independent auditor and reviews the audit report prepared by the independent auditor. The Audit Committee met 11 times during the year ended September 30, 2008. Each member of the Audit Committee is Aindependent@ in accordance with the requirements for companies listed on Nasdaq. Director Robbel has been designated by the Board of Directors as the Aaudit committee financial expert,@ as defined by the SEC. Director Robbel is a licensed Certified Public Accountant. The following table shows the compensation paid to our non-employee directors for the fiscal year ended September 30, 2008. Compensation for Michael R. Sand, who is our President and Chief Executive Officer, is included in the section below entitled AExecutive Compensation.@ We do not have any non-equity incentive plans or defined benefit plans, nor do we permit deferral of compensation on a basis that is not tax-qualified. The following table shows the compensation paid to our non-employee directors for the fiscal year ended September 30, 2008. For the year ended September 30, 2008, each of the non-employee directors received a retainer of $1,500 per month, $500 for each regular Board meeting attended, $500 for each Audit Committee meeting attended and $300 for each other committee meeting attended. In addition, each non-employee director may receive a discretionary stock-based award based on attendance criteria. Each non-employee director was granted 1,168 shares of restricted common stock under Timberland=s Management Recognition and Development Plan in December 2008 for meeting the attendance criteria during the year ended September 30, 2008.
2009-12-21	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington. He serves on the Audit Committee. Total compensation for 2009 was $34,179.
2010-12-17	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington. ... The Audit Committee consists of Directors Robbel, Smith, Mason, Goldberg and Stoney. ... The Strategic Planning and Enterprise Risk Management Committee consists of all of Timberland's independent directors, who are Directors Mason, Clinton, Smith, Robbel, Stoney and Goldberg. ... The following table shows the compensation paid to our non-employee directors for the fiscal year ended September 30, 2010. ... David A. Smith Fees Earned or Paid in Cash ($): 30,300; All Other Compensation ($): 65; Total ($): 30,365.
2011-12-19	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc. He serves on the Audit Committee. For the year ended September 30, 2011, he received $28,900 in fees.
2012-12-21	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington. He serves on the Audit Committee. Director compensation for David A. Smith was $30,400 for the fiscal year ended September 30, 2012.
2013-12-19	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington. ... Audit Committee. The Audit Committee consists of Directors Robbel, Smith, Goldberg and Stoney. The Committee meets at least quarterly and on an as needed basis to evaluate the effectiveness of our internal controls for safeguarding assets and ensuring the integrity of the financial reporting. The Committee also appoints the independent auditor and reviews the audit report prepared by the independent auditor. The Audit Committee met seven times during the year ended September 30, 2013. ... Budget Committee. The Budget Committee consists of Directors Robbel, Smith, Goldberg, Stoney and Mason. The Committee meets at least annually to review the financial projections and assumptions in the budget for the upcoming year. The Committee then presents the budget to the full Board for approval. The Budget Committee met once during the year ended September 30, 2013. ... Strategic Planning and Enterprise Risk Management Committee. The Strategic Planning and Enterprise Risk Management Committee consists of all of Timberland’s independent directors, who are Directors Mason, Clinton, Smith, Robbel, Stoney and Goldberg. The Committee meets on an as needed basis to assist the Board in identifying areas of strategic direction and opportunity, and evaluating and planning enterprise risk management with the overall primary purpose of enhancing shareholder value. The Committee met five times during the year ended September 30, 2013. ... The following table shows the compensation paid to our directors for the fiscal year ended September 30, 2013, with the exception of Michael R. Sand, who is our President and Chief Executive Officer, and whose compensation is included in the section below entitled “Executive Compensation.” ... David A. Smith 27,500 2,370 21 29,891
2014-12-19	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington. ... The Audit Committee consists of Directors Robbel, Smith, Goldberg and Stoney. ... The Budget Committee consists of Directors Robbel, Smith, Goldberg, Stoney and Mason. ... The Strategic Planning and Enterprise Risk Management Committee consists of all of Timberland’s non-employee directors, who are Directors Mason, Clinton, Parker, Smith, Robbel, Stoney and Goldberg. ... The following table shows the compensation paid to our directors for the fiscal year ended September 30, 2014 ... David A. Smith ... Total ($) 32,027.
2015-12-18	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc. ... Audit Committee consists of Directors Smith, Goldberg and Stoney. ... Budget Committee consists of Directors Smith, Goldberg, Stoney and Mason. ... Strategic Planning and Enterprise Risk Management Committee consists of Directors Mason, Clinton, Parker, Smith, Stoney and Goldberg. ... Director compensation table shows David A. Smith total compensation $34,520.
2016-12-19	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington. ... The following table shows the compensation paid to our directors for the fiscal year ended September 30, 2016... David A. Smith ... Total ($) 30,860 ... Audit Committee. The Audit Committee consists of Directors Smith, Goldberg and Stoney. ... Budget Committee. The Budget Committee consists of Directors Smith, Goldberg, Stoney and Mason. ... Strategic Planning and Enterprise Risk Management Committee consists of all of Timberland's non-employee directors, who are Directors Mason, Clinton, Parker, Smith, Stoney and Goldberg.
2017-12-18	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington.
2018-12-18	David A. Smith is a pharmacist and the owner of Harbor Drug, Inc. The following table shows the compensation paid to our directors for the fiscal year ended September 30, 2018. David A. Smith Fees Earned or Paid in Cash ($): 29,300, Option Awards ($): 4,480, Total ($): 33,780.
2019-12-18	David A. Smith is a pharmacist and the former owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington. He serves on the Audit Committee and Technology Committee. For the year ended September 30, 2019, David A. Smith received total compensation of $32,220.
2020-12-17	David A. Smith is a pharmacist and the former owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington. ... The Audit Committee consists of Directors Stoney (Chair), Davis and Smith. ... The Strategic Planning and Enterprise Risk Management Committee consists of all of Timberland’s non-employee directors, who are Directors Clinton, Davis, Goldberg (Chair), Leodler, Parker, Smith, Stoney and Suter. ... The Technology Committee consists of Directors Davis (Chair), Smith, Clinton and Suter. ... During the fiscal year ended September 30, 2020, the following compensation was paid to David A. Smith: Fees Earned or Paid in Cash ($) 32,400; Option Awards ($) 2,665; Total ($) 35,065.
2021-12-17	David A. Smith is a pharmacist and the former owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington. The following table shows the compensation paid to our directors for the fiscal year ended September 30, 2021... David A. Smith 37,440 Fees Earned or Paid in Cash ($), 6,252 Option Awards ($), 0 All Other Compensation ($), 43,692 Total ($).
2022-12-16	David A. Smith ...The directors’ current memberships on the committees is reflected below...David A. Smith: Audit Committee, Budget Committee, Nominating and Governance Committee, Strategic Planning and Enterprise Risk Management Committee ...The following table shows the compensation paid to our directors for the fiscal year ended September 30, 2022...David A. Smith: Fees Earned or Paid in Cash $39,440, Option Awards $6,882, Total $46,322.
2023-12-18	David A. Smith is a pharmacist and the former owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington... The following table shows the compensation paid to our directors for the fiscal year ended September 30, 2023... David A. Smith Fees Earned or Paid in Cash ($) 40,920, Stock Awards ($) 16,422, Total ($) 57,342.
2024-12-18	David A. Smith is a pharmacist and the former owner of Harbor Drug, Inc., a retail pharmacy located in Hoquiam, Washington. ... Each of the non-employee directors received a retainer of $3,410 per month. The Board Chair received an additional monthly retainer of $833 and each Committee Chair received an additional monthly retainer of $417, with the exception of the Budget Committee Chair, who received an additional monthly retainer of $105. No additional fees were paid for Board or committee meetings attended. Each non-employee director may periodically receive a discretionary stock-based award, if shares are available. On September 24, 2024, each non-employee director received an award of 645 shares of restricted stock. The shares vest pro rata over a three-year period from the grant date, with the first 33.3% vesting one year after the grant date.